Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-2v2mwkzPhase 3Completed
Phase 3, open-label, single-arm trial of betamethasone in preterm birth, sponsored by Faculdade de Medicina de Ribeirão Preto. Primary endpoints: Maternal betamethasone pharmacokinetics and Placental transfer of betamethasone. Started Mar 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-2v2mwkz.